Michael David Smith SEC EDGAR Filings (CIK 0001777800)

SEC EDGAR filings, ownership reports, and insider transactions for Michael David Smith.

Business address
C/O Kalvista Pharmaceuticals, Inc., 55 Cambridge Parkway, Suite 901 E, Cambridge, MA, 02142
Top holdings (ownership)
KALV
Get insider transactions for this reporting owner
Michael David Smith has filed 7 SEC EDGAR filings since 05 Jun 2019

Latest Filings

Recent SEC filings for Michael David Smith including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 19 May 2022 17 May 2022 001-36830
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Jun 2021 01 Jun 2021 001-36830
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 28 May 2021 26 May 2021 001-36830
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 30 Apr 2021 28 Apr 2021 001-36830
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 08 Feb 2021 07 Feb 2021 001-36830
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 18 Dec 2020 16 Dec 2020 001-36830
3 Open 3 document View SEC filing for 3 FORM 3 05 Jun 2019 20 May 2019 001-36830

About this filer

Michael David Smith files with the SEC under CIK 0001777800. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages